Research
Search
Close
LUO Quanyong
- Doctoral Supervisor, Professor
- Department: Nuclear Medicine
- Research Area: Imaging and Nuclear Medicine (Nuclear Medicine)
- Research Interests: Nuclear Medicine
- Contact: luoqy@sjtu.edu.cn
- MD from Shanghai Jiao Tong University School of Medicine, 2006
- Director, Department of Nuclear Medicine, Shanghai Sixth People's Hospital
- Zhang GQ, Xi C, Shen CT, Song HJ, Luo QY, Qiu ZL: Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells. Endocr Relat Cancer 2023, 30(9).
- Song H, Qiu Z, Wang Y, Xi C, Zhang G, Sun Z, Luo Q, Shen C: HIF-1α/YAP Signaling Rewrites Glucose/Iodine Metabolism Program to Promote Papillary Thyroid Cancer Progression. Int J Biol Sci 2023, 19(1):225-241.
- Lu X, Wu M, Luo Q: Development of a NIR fluorescent probe for fluorescence-assisted EGFR-TKI applicable patients screening and drug resistance monitoring. Eur J Med Chem 2023, 261:115818.
- Zhang GQ, Jiao Q, Shen CT, Song HJ, Zhang HZ, Qiu ZL, Luo QY: Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer. Cancer Sci 2021, 112(3):997-1010.
- Xi C, Zhang Q, Song HJ, Shen CT, Zhang GQ, Sun JW, Qiu ZL, Luo QY: Pregnancy Does not Affect the Prognoses of Differentiated Thyroid Cancer Patients With Lung Metastases. J Clin Endocrinol Metab 2021, 106(8):e3185-e3197.
- Song H, Chen X, Jiao Q, Qiu Z, Shen C, Zhang G, Sun Z, Zhang H, Luo QY: HIF-1α-Mediated Telomerase Reverse Transcriptase Activation Inducing Autophagy Through Mammalian Target of Rapamycin Promotes Papillary Thyroid Carcinoma Progression During Hypoxia Stress. Thyroid 2021, 31(2):233-246.
- Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W: ImmunoPET: Concept, Design, and Applications. Chem Rev 2020, 120(8):3787-3851.
- Wei W, Rosenkrans ZT, Luo QY, Lan X, Cai W: Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy. Small Methods 2019, 3(2).
- Wei W, Jiang D, Ehlerding EB, Barnhart TE, Yang Y, Engle JW, Luo QY, Huang P, Cai W: CD146-Targeted Multimodal Image-Guided Photoimmunotherapy of Melanoma. Adv Sci (Weinh) 2019, 6(9):1801237.
- Song H, Jiao Y, Wei W, Ren X, Shen C, Qiu Z, Yang Q, Wang Q, Luo QY: Can pretreatment (18)F-FDG PET tumor texture features predict the outcomes of osteosarcoma treated by neoadjuvant chemotherapy? Eur Radiol 2019, 29(7):3945-3954.
